Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy's active ingredient, semaglutide, has a half-life of roughly one week, meaning the medicine clears from your system gradually over several weeks rather than stopping sharply. Most people notice appetite returning and some weight regaining within four to twelve weeks of their last dose. What happens after you stop matters as much as the treatment itself — and the decision about whether and when to stop is one worth thinking through carefully with a prescriber. These are prescription-only medicines requiring clinical assessment; a prescriber guides every stage, including what comes next.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide clears from the body more slowly than most medicines people are familiar with. Its half-life is around seven days, which means roughly seven weeks pass before plasma levels fall to a point where pharmacological effects are minimal. You will not simply wake up one morning and feel entirely back to baseline; the taper is gradual. Appetite usually starts nudging upward within the first two to four weeks after stopping, and most of the medicine's physiological effect on gastric emptying and satiety hormones resolves within six to eight weeks. The exact timeline depends on the dose you were taking, how long you had been on it, your body composition and individual metabolism. There is no shortcut here, and anyone who tells you there is a precise number of days is reading from a simplification. For the pharmacokinetic detail, the NHS semaglutide medicines page is worth bookmarking.
One misconception worth letting go: stopping Wegovy does not trigger an immediate, dramatic reversal. The change is real, but it tends to be gradual over weeks, not sudden. Understanding that gives you more room to plan.
The STEP 1 extension trial is the clearest evidence we have. Participants who stopped semaglutide after 68 weeks regained, on average, about two-thirds of the weight they had lost within one year of stopping, even while continuing a lifestyle programme. That figure comes from the STEP 1 trial published in the New England Journal of Medicine. The biology behind it is straightforward: semaglutide works partly by suppressing appetite and slowing how quickly the stomach empties. Once those effects wear off, the underlying physiological drivers of hunger that made weight gain likely in the first place tend to reassert themselves. This is not a character flaw or a failure of effort; it reflects the chronic nature of obesity as a condition. Weight management medicines are increasingly being used as ongoing treatment for exactly this reason, rather than short-term courses. If you are researching how long treatment is typically continued, the clinical picture on stopping is part of the same conversation.
When people search for how long it takes Wegovy to wear off, the real question is often one of three things: they are wondering whether a missed pen matters; they are considering stopping and want to know what to expect; or they want to understand whether coming off treatment is reversible. All three are fair questions with real answers. A missed pen is unlikely to eliminate the medicine's effect in one week given the half-life, though appetite may feel slightly less controlled, and reading about how long Wegovy takes to work can help set realistic expectations around those fluctuations. A planned stop means preparing for appetite changes and having a lifestyle plan in place. And yes, coming off is reversible in the sense that restarting treatment is possible, subject to clinical re-assessment. If you are considering restarting and are curious about how long Wegovy takes to kick in, that detail is worth understanding before you make a final call. For a fuller view of the process of stopping Wegovy, including how prescribers approach the decision, that guide covers the detail. The broader question of what semaglutide's clearance means for the body is also covered in our piece on how long semaglutide takes to wear off.
A prescriber deciding whether to recommend stopping, pausing or continuing Wegovy will look at how much weight has been lost, what that weight loss has done for any underlying health conditions, whether the medicine is still being tolerated well, and what support structures are in place. NICE's appraisal of semaglutide under TA875 notes that treatment should be reviewed if less than five per cent of body weight is lost after six months at the maintenance dose, and sets a two-year maximum in the specialist NHS setting. Private treatment follows clinical judgement on an individual basis. The cost of treatment over time is a practical consideration for many people; our guide to Wegovy pricing covers what is included and how private prescriptions are structured. If you are close to a decision and want to talk it through, a free consultation with one of our prescribers is the most direct route forward.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.